Chinese Markets for Hepatitis Drugs

Chinese Markets for Hepatitis Drugs

Category : Pharmaceuticals
April  2012 


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
China's demand for hepatitis drugs  has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.

TABLE OF CONTENTS



I. INTRODUCTION



Report Scope and Methodology

Executive Summary



II. BUSINESS ENVIRONMENT



Economic Outlook

Key Economic Indicators

Industrial Output

Population and Labor

Foreign Investment

Foreign Trade

Financial and Tax Regulations

Banking System and Regulations

Foreign Exchange

Taxes, Tariff and Custom Duties



III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS



Hepatitis Drugs Industry Structure

Market Size

Market Growth Drivers

Hepatitis Drugs Industry Sales Volumes

Major Producer Facility Locations and Sales Volumes

Market Share of Key Producers

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investment

Technology Development



IV. HEPATITIS DRUGS PRODUCTION AND DEMAND



Overview

Sales Volumes of Hepatitis Drugs by Region in 2011

Hepatitis Drugs Sales Volumes

Liver Protection Drugs

Nucleoside Drugs

Interferon (IFN)

Other Hepatitis Drugs

Hepatitis Drugs Imports and Exports

Hepatitis Drugs Imports

Hepatitis Drugs Exports

Pricing Trend



V. HEPATITIS DRUGS MARKET OUTLOOK



Hepatitis Drugs Market Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits



VI. MARKETING STRATEGIES



China Market Entry Overview

China’s Distribution System

Hepatitis Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications



China’s Market Entry

Export to China

Indirect export

Direct Export

License and Contract Manufacture

Assembling in China

Contract Manufacturing

Trade Permit

Investment

Equity Joint Venture

Contractual Joint Venture

Wholly Foreign-Owned Enterprise



VII. HEPATITIS DRUGS PRODUCER DIRECTORY



Hepatitis Drugs Producer Profiles



LIST OF TABLES



I. INTRODUCTION



Economic Outlook Summary



II. BUSINESS ENVIRONMENT



Key Economic Indicators

Industrial Output

Population and Labor Force Trends

Foreign Investment and Loans

Foreign Trade



III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS



Hepatitis Drugs Industry Sales Volumes

Major Producer Facility Locations

Major Hepatitis Drugs Producer Sales Volumes

Market Share of Key Producers

Major Foreign Investments in China



IV. HEPATITIS DRUGS PRODUCTION AND DEMAND



Hepatitis Drugs Sales Volumes

Sales Volumes of Hepatitis Drugs by Region in 2011

Major Liver Protection Drugs Producer Sales Volumes

Liver Protection Drugs Sales Volumes

Major Nucleoside Drugs Producer Sales Volumes

Nucleoside Drugs Sales Volumes

Major IFN Drugs Producer Sales Volumes

Interferon (IFN) Sales Volumes

Other Hepatitis Drugs Sales Volumes

China Hepatitis Drugs Imports and Exports



V. HEPATITIS DRUGS MARKET OUTLOOK



Total hepatitis Drugs Sales Volumes by Market

Hepatitis Drugs Sales Volumes and Market Share in 2011

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits



LIST OF CHARTS



I. INTRODUCTION



China’s Hepatitis Drugs Sales Volumes



II. BUSINESS ENVIRONMENT



China’s GDP and Growth Rate

Industrial Output by Ownership

China’s Imports and Exports



III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS



Hepatitis Drugs Sales Volumes in China



IV. HEPATITIS DRUGS PRODUCTION AND DEMAND



Total Hepatitis Drugs Sales Volumes

Total Hepatitis Drugs Imports and Exports



V. HEPATITIS DRUGS MARKET OUTLOOK



Hepatitis Drugs Sales Volumes by Market in 2011



VI. MARKETING STRATEGIES



China’s Distribution Channel



Enquiry Before Buy